Skip to main content
Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqywww.alexion.com

Search complete. 11 mentions across 5 episodes found for "Alexion Pharmaceuticals".

Sep 25, 2026

Paul MatteisHOST
29:02
And Eric, you know, when you kinda brought up that thematic discussion, I was trying to think about other companies I've covered, right, who had these special drug franchises that went from these mega high multiple stocks to ones where competition became this existential bear case.
Paul MatteisHOST
29:16
L- Alexion kinda came up to my mind first, but yeah, maybe I'll leave it to you to lead the conversation on that and others can chime in and I can maybe come back at some point.
Eric SchmidtHOST
29:26
Well just first, maybe a specific question on Sionna versus Vertex.
Eric SchmidtHOST
29:29
Is, is Sionna's setback, you think more, uh, of a, of a Sionna specific or idiosyncratic issue or does it really speak to the big moat that Vertex has and that moat is impenetrable in your view?
Eric SchmidtHOST
32:44
Well, interesting point that you raised, Josh, that, uh, sticking to one's knitting might be part of building this mode.
Eric SchmidtHOST
32:50
Interestingly, uh, Insight's actually kind of coming back to MPNs and probably is now double dow-double down on that area of medicine that created Jakafi.
Eric SchmidtHOST
33:01
Then Paul brought up Alexion earlier.
Eric SchmidtHOST
33:03
Um, I mean, we all want moats.
Raymond TarrGUEST
2:37
So I've always looked at driving new testing, building new tests, building new systems.
Raymond TarrGUEST
2:43
Recently migrated over to Alexion, which became AstraZeneca.
Raymond TarrGUEST
2:47
My role there was to speed up the diagnosis for patients that have rare disorders.
Raymond TarrGUEST
2:53
And it was really eye-opening.
Raymond TarrGUEST
5:23
Continued to grow my career up through at Cepheid as an example.
Raymond TarrGUEST
5:26
On the commercial side, I was the GM for Asia Pacific.
Raymond TarrGUEST
5:30
And so... started that program pushing basically the PCR across the greater Asia hemisphere there so managed to do that work and then I've been the head of diagnostics at AstraZeneca as an example to AstraZeneca Alexion as well.
David FilbyHOST
5:46
What was it like going on to that side of the industry onto the therapeutic side but still obviously in a diagnostics capacity and was that your first exposure to rare disease as well?
Clayton ThomasGUEST
11:03
And she was one of the attendees.
Clayton ThomasGUEST
11:06
And when you're amongst one of her colleagues that she used to work with at Alexion, who's an MD, that's probably going to win the Nobel Prize in Science because he's working on and has figured out a lot of the genetic components to cancer.
Clayton ThomasGUEST
11:21
And they're they're working really, really intently on creating human monoclonal antibodies and to specifically target specific genes in a specific diagnosis.
Clayton ThomasGUEST
11:34
Right.
Linda EskewHOST
0:37
We have been on a little summer hiatus and so we are kicking things off with a really great topic.
Linda EskewHOST
0:45
Today I'm joined by Leal Tidwell, who is a PhD and a senior medical science liaison with Alexion working in rare neurology.
Linda EskewHOST
0:53
Leal has one of those careers that's really taken a few interesting turns along the way.
Linda EskewHOST
0:58
She started out in academia and earned her PhD in neurobiology and anatomy from Wake Forest and completed postdoctoral training at Georgetown before moving into intellectual property and technology transfer through some roles with NIH and the US government, nonprofit and academic organizations.
Linda EskewHOST
1:22
which ultimately led her into the medical affairs industry and into MSL type roles in orthobiologics and medical devices.
Linda EskewHOST
1:30
And from there, she spent time in the CRO world learning more about clinical trial management and then joined ALK where she spent six years in allergy immunotherapy and took on everything from multiple territories and clinical operations to global cross-functional work and subject matter expertise.
Linda EskewHOST
1:51
Most recently, Leal came full circle in a way and returned to her roots in neurobiology when she joined Alexion in rare neurology, where she is now.
Linda EskewHOST
1:59
Along the way, she's also been navigating a whole other full-time role, which we're going to be talking about more today, and that is being a mom while building a career that involves travel, flexibility, and a whole lot of logistics.
Kimberly NashHOST
9:26
How did they get in touch with you or how did all this become about? So I'm not
Deanna SteinleGUEST
9:31
sure how I landed on Alexion's radar.
Deanna SteinleGUEST
9:35
But I'm very grateful that I did.
Deanna SteinleGUEST
9:37
But they reached out and they said, Deanna, we, you know, you've been an advocate.
Deanna SteinleGUEST
10:20
the box which i stand on because you can have all the things happen in the world to you but if the person next to you just doesn't get it or you don't recognize that they get it that breakdown communication is huge and that is why the film was just so important
Kimberly NashHOST
10:39
where can a listener find this i mean what what's the name of it and and where can they go to find this episode
Deanna SteinleGUEST
10:48
The episode for Rare Connections GMG is on the Alexion YouTube page.
Deanna SteinleGUEST
10:54
It's also on their website.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.